Free Trial
Your Portfolio Deserves Better! MarketBeat All Access for Just $149
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Upgrade Now
Claim MarketBeat All Access Sale Promotion

Firefly Neuroscience (AIFF) 10K Form and Latest SEC Filings 2026

Firefly Neuroscience logo
$1.75 +0.04 (+2.34%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$1.72 -0.02 (-1.43%)
As of 05/22/2026 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Firefly Neuroscience SEC Filings & Recent Activity

Firefly Neuroscience (NASDAQ:AIFF) has submitted 251+ documents to the U.S. Securities and Exchange Commission (SEC) since 2018. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. The most recent filing was a Form S-8 submitted on May 20, 2026.

Form 4
FIREFLY NEUROSCIENCE, INC. Reports Ownership Change on Mar. 12, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Firefly Neuroscience Files Current Report on May. 12, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-K
Firefly Neuroscience Files Annual Report on Mar. 31, 2026

The 10-K contains Firefly Neuroscience's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

Firefly Neuroscience SEC Filing History

Browse Firefly Neuroscience's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/20/2026 7:30 AM
Firefly Neuroscience (803578) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/20/2026 7:00 AM
Firefly Neuroscience (803578) Filer
Form S-3
Registration statement under Securities Act of 1933  
05/12/2026 3:30 PM
Firefly Neuroscience (803578) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2026 3:30 PM
Firefly Neuroscience (803578) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2026 8:55 AM
Firefly Neuroscience (803578) Filer
Form D
Notice of Exempt Offering of Securities 
03/31/2026 6:38 AM
Firefly Neuroscience (803578) Filer
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2026 3:30 PM
Firefly Neuroscience (803578) Issuer
Lipschitz Gregory (2044426) Reporting
Form 3/A
03/12/2026 3:30 PM
Firefly Neuroscience (803578) Issuer
Lipschitz Gregory (2044426) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2026 6:52 PM
Firefly Neuroscience (803578) Subject
Windsor Private Capital LP (2034160) Filed by
Form SCHEDULE 13D/A
12/31/2025 6:20 PM
Firefly Neuroscience (803578) Subject
Windsor Private Capital LP (2034160) Filed by
Form SCHEDULE 13D/A
12/19/2025 4:15 PM
Firefly Neuroscience (803578) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2025 7:33 PM
Firefly Neuroscience (803578) Subject
Windsor Private Capital LP (2034160) Filed by
Form SCHEDULE 13D/A
12/07/2025 11:15 PM
Firefly Neuroscience (803578) Filer
Form EFFECT
12/03/2025 4:00 PM
Firefly Neuroscience (803578) Filer
Form S-3
Registration statement under Securities Act of 1933  
11/17/2025 8:05 PM
Firefly Neuroscience (803578) Filer
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/14/2025 3:41 PM
Arena Investors LP (1699673) Filed by
Firefly Neuroscience (803578) Subject
Form SCHEDULE 13G/A
11/12/2025 5:06 AM
Firefly Neuroscience (803578) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2025 4:32 PM
Firefly Neuroscience (803578) Subject
Windsor Private Capital LP (2034160) Filed by
Form SCHEDULE 13D/A
10/31/2025 3:15 PM
Firefly Neuroscience (803578) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2025 2:48 PM
Firefly Neuroscience (803578) Issuer
Menawat Arun Swarup (1685893) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2025 2:46 PM
Firefly Neuroscience (803578) Issuer
Vnook Stella (2037643) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2025 2:47 PM
Firefly Neuroscience (803578) Issuer
POSNER BRIAN M (1287711) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2025 5:39 PM
Firefly Neuroscience (803578) Subject
Windsor Private Capital LP (2034160) Filed by
Form SCHEDULE 13D/A
10/23/2025 7:50 AM
Firefly Neuroscience (803578) Filer
Form DEFR14A
10/22/2025 5:36 PM
Cundari John (2034031) Reporting
Firefly Neuroscience (803578) Issuer
HJR Kupinsky 2013 Family Trust (2034429) Reporting
HJRK Holdings Inc. (2034082) Reporting
Kupinsky Jordan (1544321) Reporting
Marcello Rocco (2034039) Reporting
Windsor Private Capital LP (2034160) Reporting
WPC GP I Inc. (2034166) Reporting
WPC Management Services Inc. (2034112) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2025 5:32 PM
Firefly Neuroscience (803578) Subject
Windsor Private Capital LP (2034160) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2025 5:53 PM
Firefly Neuroscience (803578) Subject
Windsor Private Capital LP (2034160) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/20/2025 7:46 PM
Firefly Neuroscience (803578) Subject
Windsor Private Capital LP (2034160) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/17/2025 7:03 PM
Firefly Neuroscience (803578) Subject
Windsor Private Capital LP (2034160) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/17/2025 7:04 PM
Cundari John (2034031) Reporting
Firefly Neuroscience (803578) Issuer
HJR Kupinsky 2013 Family Trust (2034429) Reporting
HJRK Holdings Inc. (2034082) Reporting
Kupinsky Jordan (1544321) Reporting
Marcello Rocco (2034039) Reporting
Windsor Private Capital LP (2034160) Reporting
WPC GP I Inc. (2034166) Reporting
WPC Management Services Inc. (2034112) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2025 5:09 PM
Firefly Neuroscience (803578) Subject
Windsor Private Capital LP (2034160) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2025 7:57 PM
Firefly Neuroscience (803578) Subject
Windsor Private Capital LP (2034160) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2025 7:58 PM
Firefly Neuroscience (803578) Subject
Windsor Private Capital LP (2034160) Filed by
Form SCHEDULE 13D/A
10/14/2025 6:15 PM
Cundari John (2034031) Reporting
Firefly Neuroscience (803578) Issuer
HJR Kupinsky 2013 Family Trust (2034429) Reporting
HJRK Holdings Inc. (2034082) Reporting
Kupinsky Jordan (1544321) Reporting
Marcello Rocco (2034039) Reporting
Windsor Private Capital LP (2034160) Reporting
WPC GP I Inc. (2034166) Reporting
WPC Management Services Inc. (2034112) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2025 6:12 PM
Firefly Neuroscience (803578) Subject
Windsor Private Capital LP (2034160) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2025 7:28 PM
Firefly Neuroscience (803578) Subject
Windsor Private Capital LP (2034160) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/09/2025 6:06 PM
Firefly Neuroscience (803578) Subject
Windsor Private Capital LP (2034160) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/03/2025 7:01 AM
Firefly Neuroscience (803578) Filer
Form DEF 14A
08/29/2025 3:17 PM
Firefly Neuroscience (803578) Filer
Form 424B3
07/22/2025 11:15 PM
Firefly Neuroscience (803578) Filer
Form EFFECT
06/16/2025 3:17 PM
Firefly Neuroscience (803578) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Your book attached (Ad)

Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners guide...please take a few seconds and download it right now before your download link expires. That way, no matter what it costs in the future, you'll have a free copy on your computer.tc pixel

Simple Options Trading For Beginners (Download Link Expires)...
(Data available from 1/1/2016 forward)

Firefly Neuroscience SEC Filings - Frequently Asked Questions

Firefly Neuroscience (AIFF) has submitted 251+ filings to the SEC since 2018. You can browse the complete history or filter by form type using the tools above.

Firefly Neuroscience's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results.

The most recent filing was a Form S-8 submitted on May 20, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:AIFF) was last updated on 5/23/2026 by MarketBeat.com Staff.
From Our Partners